These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Neuroendocrine cell hyperplasia and neuroendocrine carcinoma of the rodent fundic stomach. Poynter D; Selway SA Mutat Res; 1991 Jun; 248(2):303-19. PubMed ID: 2046687 [TBL] [Abstract][Full Text] [Related]
28. Omeprazole: a comprehensive review. Massoomi F; Savage J; Destache CJ Pharmacotherapy; 1993; 13(1):46-59. PubMed ID: 8437967 [TBL] [Abstract][Full Text] [Related]
29. Hemolytic anemia associated with the use of omeprazole. Marks DR; Joy JV; Bonheim NA Am J Gastroenterol; 1991 Feb; 86(2):217-8. PubMed ID: 1992636 [TBL] [Abstract][Full Text] [Related]
30. [Omeprazole and peptic ulcer. Profile of a new active agent]. Müller P; Dammann HG; Simon B Fortschr Med; 1987 Jan; 105(2):35-8. PubMed ID: 3557254 [No Abstract] [Full Text] [Related]
31. The role of omeprazole in healing and prevention of reflux disease. Klinkenberg-Knol EC Hepatogastroenterology; 1992 Feb; 39 Suppl 1():27-30. PubMed ID: 1577392 [TBL] [Abstract][Full Text] [Related]
32. Use of omeprazole in patients with Zollinger-Ellison syndrome. Frucht H; Maton PN; Jensen RT Dig Dis Sci; 1991 Apr; 36(4):394-404. PubMed ID: 2007355 [TBL] [Abstract][Full Text] [Related]
33. [Omeprazole long-term therapy: how great is the risk of developing a carcinoid tumor?]. Koop H Z Gastroenterol; 1988 Dec; 26(12):769-71. PubMed ID: 3149827 [No Abstract] [Full Text] [Related]
34. [Omeprazole--a drug-blocking proton pump of the parietal cells of the stomach]. Sosnowski M Pol Tyg Lek; 1985 Dec 23-30; 40(51-52):1469-72. PubMed ID: 3008128 [No Abstract] [Full Text] [Related]
35. Development of sustained achlorhydria in a patient with the Zollinger-Ellison syndrome treated with omeprazole. Griffith JL; Cummings OW; Hirschowitz BI Gastroenterology; 1991 Jul; 101(1):242-6. PubMed ID: 1796940 [TBL] [Abstract][Full Text] [Related]
36. Gastric carcinoid tumours in patients with Zollinger-Ellison syndrome on long-term omeprazole. Goldfain D; le Bodic MF; Lavergne A; Galian A; Modigliani R Lancet; 1989 Apr; 1(8641):776-7. PubMed ID: 2564577 [No Abstract] [Full Text] [Related]
37. The clinical safety of omeprazole. Sölvell L Digestion; 1990; 47 Suppl 1():59-63; discussion 76. PubMed ID: 2093017 [TBL] [Abstract][Full Text] [Related]
38. [Reduction of gastric acid secretion: pathophysiologic and clinically relevant sequelae]. Koop H; Eissele R Z Gastroenterol; 1991 Nov; 29(11):613-7. PubMed ID: 1685286 [TBL] [Abstract][Full Text] [Related]
39. Qualitative studies of gastric endocrine cells in patients treated long-term with omeprazole. Solcia E; Rindi G; Havu N; Elm G Scand J Gastroenterol Suppl; 1989; 166():129-37; discussion 138-9. PubMed ID: 2513643 [TBL] [Abstract][Full Text] [Related]
40. Combined use of omeprazole and a novel antioxidative cytoprotectant for the treatment of peptic ulcer. Facilitation of ulcer healing in experimental animals. Kim JM; Choi SM; Kim DH; Oh TY; Ahn BO; Kwon JW; Kim WB Arzneimittelforschung; 2005; 55(7):387-93. PubMed ID: 16080278 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]